Human Molecular Genetics, Vol 5, 1931-1937, Copyright © 1996 by Oxford University Press
L Yuan, N Qian and B Tycko
There is increasing evidence for chromosomal domains containing multiple
imprinted genes and for domain-wide disruption of imprinting in certain
diseases. In a majority of Wilms' tumors (WTs) there is an abnormal
bipaternal pattern of expression at three imprinted loci, H19, IGF2 and
KIP2, clustered on chromosome 11p15.5. We previously described biallelic
expression of L23MRP, 40 kb downstream of H19. Here we map two additional
genes, the first encoding a ubiquitously expressed RNA, 2G7, and the second
encoding the fast isoform of skeletal muscle troponin-T (TNNT3), in the 55
kb of DNA downstream of L23MRP. 2G7 RNA is spliced and polyadenylated but
lacks long open reading frames. 2G7 and TNNT3 are biallelically expressed
in mid-fetal and adult human tissues and 2G7 shows persistent expression in
WTs. The rat homologue of L23MRP is highly conserved and lies within 85 kb
of H19 in a region of rat chromosome 1 which also contains IGF2 and TNNT3.
Parallel expression of H19 and TNNT3 in different adult skeletal muscle
types suggests that these genes may share an enhancer. These data outline
multiple contiguous loci downstream of H19 which escape functional
imprinting in humans. The rodent-human synteny of this region may
facilitate a search for an imprinting domain boundary.
ARTICLES
An extended region of biallelic gene expression and rodent-human synteny downstream of the imprinted H19 gene on chromosome 11p15.5
Department of Pathology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. R. Kaffer, A. Grinberg, and K. Pfeifer Regulatory Mechanisms at the Mouse Igf2/H19 Locus Mol. Cell. Biol., December 1, 2001; 21(23): 8189 - 8196. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ainscough, T Koide, M Tada, S Barton, and M. Surani Imprinting of Igf2 and H19 from a 130 kb YAC transgene Development, January 9, 1997; 124(18): 3621 - 3632. [Abstract] [PDF] |
||||

